SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
3

Initial filing by director officer or owner of more than ten percent

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent

3,4,5
View HTML
15-12B

Termination of registration under Section 12(g) or suspension of duty to file reports

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

Other
View HTML

Data provided by Kaleidoscope.